Loredana Siani | PHD

Loredana recently joined Nouscom as the Technical Director from Reithera. She has fifteen years of industry experience spanning process development and GMP production of viral vectored vaccines. [...]


Patricia Delaite | MD

Patricia joined Nouscom in January 2020 as Chief Medical Officer from AMAL Therapeutics where she acted as CMO. Prior to AMAL, Patricia spent 15 years in biopharmaceutical clinical development, [...]


Nouscom Strengthens its Management Team

Marina Udier, PhD, appointed as Chief Executive Officer and Patricia Delaite, MD, appointed as Chief Medical Officer BASEL, Switzerland – 26. February 2020: Nouscom, an immuno-oncology company [...]

page 1 of 4